Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Celgene Acquires Cancer Drug Start-Up in $7B Deal

The biopharmaceutical company Celgene Corp. is acquiring Impact Biomedicines Inc., a developer of drugs to treat a type of blood-related cancer, in a deal valued as much as $7 billion. . . . → Read More: Celgene Acquires Cancer Drug Start-Up in $7B Deal

Sangamo, Pfizer Partner on ALS Gene Therapy

Drug maker Pfizer Inc. is licensing and collaborating on a gene therapy technology from Sangamo Therapeutics Inc. to treat amyotrophic lateral sclerosis, or ALS, and a related neurodegenerative disease. . . . → Read More: Sangamo, Pfizer Partner on ALS Gene Therapy

RNA Therapies Start-Up Raises $55.3M in Early Funds

A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round. . . . → Read More: RNA Therapies Start-Up Raises $55.3M in Early Funds

Audio-Brain Stimulation Shown to Reduce PTSD Symptoms

A clinical trial shows a non-invasive technique that translates and feeds back brain waves as audio tones reduces PTSD symptoms in current and former military personnel for 6 months. . . . → Read More: Audio-Brain Stimulation Shown to Reduce PTSD Symptoms

Super High-Resolution Photo Sensor Developed

Engineers at Dartmouth College developed a sensor that captures light signals at high speed and resolution down to the level of individual photons. . . . → Read More: Super High-Resolution Photo Sensor Developed

Biotechs Partner on HPV Cancer Immunotherapies

Biotechnology companies in the U.S. and the Netherlands are collaborating on treatments for cancers caused by a type of human papillomavirus, or HPV. . . . → Read More: Biotechs Partner on HPV Cancer Immunotherapies

Survey: More Research Patents, Start-Ups in 2016

A survey of universities and other institutions shows the number of patent filings and new start-up companies resulting from federally-funded research climbed in 2016. . . . → Read More: Survey: More Research Patents, Start-Ups in 2016

Biotech, Cancer Center Partner on T-Cell Research

A developer of cancer diagnostics and treatments is collaborating with Moffitt Cancer Center to advance therapies for ovarian cancer with T-cells from the immune system. . . . → Read More: Biotech, Cancer Center Partner on T-Cell Research

Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal

Bayer AG, the global drug maker and agricultural chemical company, is partnering with a Japanese biologics enterprise to discover a series of peptides for therapies. . . . → Read More: Bayer Acquiring Therapeutic Peptides in $1.1B+ Deal

Biotech Licenses Mayo Clinic Microbiome Research

A biotechnology company developing therapies with specialized gut microbes is licensing research from the Mayo Clinic on these microbes’ effects with autoimmune diseases. . . . → Read More: Biotech Licenses Mayo Clinic Microbiome Research